327 research outputs found
<Abstract of published report>Secoiridoid, Coumarin and Coumarin-secoiridoidglucosides from Fraxinus chinensis.
Calcium-sensing receptors regulate cardiomyocyte Ca2+ signaling via the sarcoplasmic reticulum-mitochondrion interface during hypoxia/reoxygenation
Communication between the SR (sarcoplasmic reticulum, SR) and mitochondria is important for cell survival and apoptosis. The SR supplies Ca2+ directly to mitochondria via inositol 1,4,5-trisphosphate receptors (IP3Rs) at close contacts between the two organelles referred to as mitochondrion-associated ER membrane (MAM). Although it has been demonstrated that CaR (calcium sensing receptor) activation is involved in intracellular calcium overload during hypoxia/reoxygenation (H/Re), the role of CaR activation in the cardiomyocyte apoptotic pathway remains unclear. We postulated that CaR activation plays a role in the regulation of SR-mitochondrial inter-organelle Ca2+ signaling, causing apoptosis during H/Re. To investigate the above hypothesis, cultured cardiomyocytes were subjected to H/Re. We examined the distribution of IP3Rs in cardiomyocytes via immunofluorescence and Western blotting and found that type 3 IP3Rs were located in the SR. [Ca2+]i, [Ca2+]m and [Ca2+]SR were determined using Fluo-4, x-rhod-1 and Fluo 5N, respectively, and the mitochondrial membrane potential was detected with JC-1 during reoxygenation using laser confocal microscopy. We found that activation of CaR reduced [Ca2+]SR, increased [Ca2+]i and [Ca2+]m and decreased the mitochondrial membrane potential during reoxygenation. We found that the activation of CaR caused the cleavage of BAP31, thus generating the pro-apoptotic p20 fragment, which induced the release of cytochrome c from mitochondria and the translocation of bak/bax to mitochondria. Taken together, these results reveal that CaR activation causes Ca2+ release from the SR into the mitochondria through IP3Rs and induces cardiomyocyte apoptosis during hypoxia/reoxygenation
<Abstract of published report>Isolation of Oleayunnanoside from Fruxinus insularis and Revision of Its Stucture to Insularoside-6\u27"-O-β-D-Glucoside.
Mouse Strain– and Charge-Dependent Vessel Permeability of Nanoparticles at the Lower Size Limit
Remarkable advancement has been made in the application of nanoparticles (NPs) for cancer therapy. Although NPs have been favorably delivered into tumors by taking advantage of the enhanced permeation and retention (EPR) effect, several physiological barriers present within tumors tend to restrict the diffusion of NPs. To overcome this, one of the strategies is to design NPs that can reach lower size limits to improve tumor penetration without being rapidly cleared out by the body. Several attempts have been made to achieve this, such as selecting appropriate nanocarriers and modifying surface properties. While many studies focus on the optimal design of NPs, the influence of mouse strains on the effectiveness of NPs remains unknown. Therefore, this study aimed to assess whether the vascular permeability of NPs near the lower size limit differs among mouse strains. We found that the vessel permeability of dextran NPs was size-dependent and dextran NPs with a size below 15 nm exhibited leakage from postcapillary venules in all strains. Most importantly, the leakage rate of 8-nm fluorescein isothiocyanate dextran was significantly higher in the BALB/c mouse strain than in other strains. This strain dependence was not observed in slightly positive TRITC-dextran with comparable sizes. Our results indicate that the influence on mouse strains needs to be taken into account for the evaluation of NPs near the lower size limit
Phyllaemblicin B inhibits Coxsackie virus B3 induced apoptosis and myocarditis.
Coxsackie virus B3 (CVB3) is believed to be a major contributor to viral myocarditis since virus-associated apoptosis plays a role in the pathogenesis of experimental myocarditis. In this study, we investigated the in vitro and in vivo antiviral activities of Phyllaemblicin B, the main ellagitannin compound isolated from Phyllanthus emblica, a Chinese herb medicine, against CVB3. Herein we report that Phyllaemblicin B inhibited CVB3-mediated cytopathic effects on HeLa cells with an IC(50) value of 7.75+/-0.15microg/mL. In an in vivo assay, treatment with 12mgkg(-1)d(-1) Phyllaemblicin B reduced cardiac CVB3 titers, decreased the activities of LDH and CK in murine serum, and alleviated pathological damages of cardiac muscle in myocarditic mice. Moreover, Phyllaemblicin B clearly inhibited CVB3-associated apoptosis effects both in vitro and in vivo. These results show that Phyllaemblicin B exerts significant antiviral activities against CVB3. Therefore, Phyllaemblicin B may represent a potential therapeutic agent for viral myocarditis
Beauty, Symmetry, and Magnetocaloric Effect-Four-Shell Keplerates with 104 Lanthanide Atoms
通讯作者地址: Kong, XJThe hydrolysis of Ln(ClO4)(3) in the presence of acetate leads to the assembly of the three largest known lanthanide-exclusive cluster complexes, [Nd-104(ClO4)(6)(CH3COO)(60)(mu(3)-OH)(168)(mu(4)-O)(30)(H2O)(112)].(ClO4)(18).(CH3CH2OH)(8).xH(2)O (1, x approximate to 158) and [Ln(104)(ClO4)(6)(CH3COO)(56)(mu(3)-OH)(168)(mu(4)-O)(30)(H2O)(112)].(ClO4)(22).(CH3CH2OH)(2).xH(2)O (2, Ln = Nd; 3, Ln = Gd; x approximate to 140). The structure of the common 104-lanthanide core, abbreviated as Ln(8)@Ln(48)@Ln(24)@Ln(24), features a four-shell arrangement of the metal atoms contained in an innermost cube (a Platonic solid) and, moving outward, three Archimedean solids: a truncated cuboctahedron, a truncated octahedron, and a rhombicuboctahedron. The magnetic entropy change of Delta Sm = 46.9 J kg(-1) K-1 at 2 K for Delta H = 7 T in the case of the Gd-104 cluster is the largest among previously known lanthanide-exclusive cluster compounds.973 Project from the Ministry of Science and Technology of China
2012CB821704
2014CB845601
National Natural Science Foundation of China
21422106
21371144
21431005
21390391
Foundation for the Author of National Excellent Doctoral Dissertation of China
201219
U.S. NSF
APVV-0132-11
3001690
Czech Research Infrastructures
LM201102
- …